Claudia Blattmann

3.0k total citations
37 papers, 491 citations indexed

About

Claudia Blattmann is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Claudia Blattmann has authored 37 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 12 papers in Rheumatology and 11 papers in Molecular Biology. Recurrent topics in Claudia Blattmann's work include Sarcoma Diagnosis and Treatment (26 papers), Bone Tumor Diagnosis and Treatments (11 papers) and Histone Deacetylase Inhibitors Research (6 papers). Claudia Blattmann is often cited by papers focused on Sarcoma Diagnosis and Treatment (26 papers), Bone Tumor Diagnosis and Treatments (11 papers) and Histone Deacetylase Inhibitors Research (6 papers). Claudia Blattmann collaborates with scholars based in Germany, Austria and Switzerland. Claudia Blattmann's co-authors include Andreas E. Kulozik, Susanne Oertel, Jürgen Debus, Peter E. Huber, Markus Thiemann, Volker Ehemann, Marc Bischof, Olaf Witt, Stephanie E. Combs and Stefan Bielack and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Claudia Blattmann

35 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Blattmann Germany 14 237 235 109 71 68 37 491
Coralie Moncharmont France 9 157 0.7× 160 0.7× 204 1.9× 83 1.2× 21 0.3× 26 437
David Milewski United States 12 345 1.5× 226 1.0× 78 0.7× 91 1.3× 9 0.1× 20 548
Helen B. Forrester Australia 16 282 1.2× 203 0.9× 159 1.5× 121 1.7× 25 0.4× 28 637
Masako Uno Japan 12 180 0.8× 87 0.4× 148 1.4× 57 0.8× 11 0.2× 38 528
Naoyuki Okabe Japan 15 212 0.9× 255 1.1× 392 3.6× 197 2.8× 15 0.2× 56 706
Fu-Min Fang Taiwan 16 250 1.1× 248 1.1× 208 1.9× 135 1.9× 57 0.8× 21 649
Frank He United States 7 278 1.2× 102 0.4× 175 1.6× 75 1.1× 13 0.2× 7 483
Sandra Tomek Austria 11 243 1.0× 189 0.8× 263 2.4× 113 1.6× 10 0.1× 17 599
Jeffrey S. Eshleman United States 8 184 0.8× 167 0.7× 136 1.2× 56 0.8× 6 0.1× 13 510

Countries citing papers authored by Claudia Blattmann

Since Specialization
Citations

This map shows the geographic impact of Claudia Blattmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Blattmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Blattmann more than expected).

Fields of papers citing papers by Claudia Blattmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Blattmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Blattmann. The network helps show where Claudia Blattmann may publish in the future.

Co-authorship network of co-authors of Claudia Blattmann

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Blattmann. A scholar is included among the top collaborators of Claudia Blattmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Blattmann. Claudia Blattmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreou, Dimosthenis, Claudia Blattmann, Godehard Friedel, et al.. (2026). Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS). Journal of Cancer Research and Clinical Oncology. 152(1). 40–40.
2.
Bielack, Stefan, Daniel Baumhoer, Andreas Beilken, et al.. (2025). Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS ). Cancer Medicine. 14(17). e71211–e71211. 1 indexed citations
3.
Kościelniak, Ewa, Sabine Stegmaier, Gustaf Ljungman, et al.. (2025). Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS. Cancer Medicine. 14(1). e70215–e70215. 1 indexed citations
4.
Daigeler, Adrien, Jens Jakob, Bernd Kasper, et al.. (2025). An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approach. Frontiers in Oncology. 15. 1592004–1592004.
5.
Blattmann, Claudia, Godehard Friedel, Semi Harrabi, et al.. (2024). Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group. Cancers. 16(2). 275–275. 4 indexed citations
6.
Blattmann, Claudia, Stefanie Hecker‐Nolting, Leo Kager, et al.. (2024). Beyond 5‐year survival. A report from the Cooperative Osteosarcoma Study Group (COSS). Cancer Medicine. 13(1). e6893–e6893. 3 indexed citations
7.
Bielack, Stefan, Stefanie Hecker‐Nolting, Arndt Borkhardt, et al.. (2024). Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS). Pediatric Blood & Cancer. 71(12). e31344–e31344. 1 indexed citations
8.
Zhou, Yang, Partho Sarothi Ray, Jianguo Zhu, et al.. (2024). Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma. Nature Communications. 15(1). 2810–2810. 5 indexed citations
9.
Bielack, Stefan, Leo Kager, Thomas Kühne, et al.. (2023). Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). Cancers. 15(5). 1520–1520. 7 indexed citations
10.
Fuchs, Jörg, Abbas Agaimy, Christian Vokuhl, et al.. (2023). Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence—an analysis of the German Registry for Rare Pediatric Tumors (STEP). European Journal of Pediatrics. 182(12). 5341–5352. 4 indexed citations
11.
Baumhoer, Daniel, Stefan Bielack, Claudia Blattmann, et al.. (2023). Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group. Cancer Medicine. 12(17). 18219–18234. 3 indexed citations
12.
Bodmer, Nicole, Stefanie Hecker‐Nolting, Godehard Friedel, et al.. (2023). Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group. Cancer. 129(12). 1895–1903. 1 indexed citations
13.
Bielack, Stefan, Lars H. Lindner, Gerlinde Egerer, et al.. (2023). Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group. Journal of Geriatric Oncology. 14(3). 101445–101445. 1 indexed citations
14.
Blattmann, Claudia, Stefan Bielack, Leo Kager, et al.. (2022). Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer. 128(9). 1787–1800. 11 indexed citations
15.
Hecker‐Nolting, Stefanie, Leo Kager, Thomas Kühne, et al.. (2022). Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of Adolescent and Young Adult Oncology. 12(1). 76–82. 2 indexed citations
16.
Hecker‐Nolting, Stefanie, Thor s ten Langer, Claudia Blattmann, Leo Kager, & Stefan Bielack. (2021). Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients. Cancer Management and Research. Volume 13. 8989–8998. 7 indexed citations
17.
Blattmann, Claudia, Markus Thiemann, Albrecht Stenzinger, et al.. (2015). Establishment of a patient-derived orthotopic osteosarcoma mouse model. Journal of Translational Medicine. 13(1). 136–136. 38 indexed citations
18.
Blattmann, Claudia, Susanne Oertel, Markus Thiemann, et al.. (2015). Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. Radiation Oncology. 10(1). 146–146. 15 indexed citations
19.
Combs, Stephanie E., Kerstin A. Kessel, Klaus Herfarth, et al.. (2012). Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiation Oncology. 7(1). 170–170. 42 indexed citations
20.
Altamura, Sandro, et al.. (2009). SELDI-TOF MS detection of urinary hepcidin. Biochimie. 91(10). 1335–1338. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Coralie Moncharmont Breakdown of academic impact, for papers by David Milewski Breakdown of academic impact, for papers by Helen B. Forrester Breakdown of academic impact, for papers by Masako Uno Breakdown of academic impact, for papers by Naoyuki Okabe Breakdown of academic impact, for papers by Fu-Min Fang Breakdown of academic impact, for papers by Frank He Breakdown of academic impact, for papers by Sandra Tomek Breakdown of academic impact, for papers by Jeffrey S. Eshleman
Rankless by CCL
2026